Adding LH hormone in IVF for women 35-40
Part of Women’s health & pregnancy clinical trials.
This trial tests whether adding a hormone (r-hLH) to standard ovarian stimulation medicine helps women aged 35 to 40 produce more eggs during IVF. It may be a good option if you have lower ovarian reserve and are starting your first or second IVF cycle.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 35 and 40 years old.
- Your body mass index (BMI) is between 18.5 and 28.
- This is your first or second time doing IVF or a related fertility treatment.
- You will use sperm from ejaculation, not from a surgical procedure.
- You have not had two or more miscarriages or two or more IVF failures.
- You do not have certain medical conditions (like severe endometriosis, diabetes, or hormone problems).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding a personalized amount of “LH” during IVF hormone stimulation can help your ovaries respond better. It may be useful if you’ve had a weaker IVF response before and fit specific age and egg-quality markers.
This trial tests a fertility drug called follitropin delta for women undergoing IVF. It checks if using this drug with a specific hormone-lowering protocol helps produce eggs for fertilisation.
This trial tests whether adding growth hormone and DHEA to your IVF medications can help women with low ovarian reserve get more eggs and improve pregnancy chances. It may be an option if you are over 40, have had few eggs before, or have low egg count markers.
This study tests if a combination of two hormone drugs (follitropin alfa/lutropin alfa) works as well as another drug (hMG) for Japanese women with low LH and FSH levels who are doing in vitro fertilization (IVF). The goal is to help them produce eggs for pregnancy.
This study looks at how follitropin delta is used in real clinics to help women stimulate eggs for IVF or ICSI. It may help doctors fine-tune dosing by comparing outcomes in everyday practice.
This trial tests a fertility injection called Corifollitropin alfa to help women aged 36–40 produce eggs for in-vitro fertilization (IVF). Researchers want to confirm it is safe and effective in this age group using a specific ovarian stimulation protocol.
Hear when a new Infertility trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.